Mai Asakura , Kazuya Toriumi , Aya Nozaki , Jinwei Yang , Jin Tatsuzaki , Kazuhiro Suzuki , Mitsuhiro Miyashita , Masanari Itokawa , Makoto Arai
{"title":"花青素是喷托苷合成的强效抑制剂:抗氧化作用。","authors":"Mai Asakura , Kazuya Toriumi , Aya Nozaki , Jinwei Yang , Jin Tatsuzaki , Kazuhiro Suzuki , Mitsuhiro Miyashita , Masanari Itokawa , Makoto Arai","doi":"10.1016/j.bbrc.2024.151007","DOIUrl":null,"url":null,"abstract":"<div><div>Pentosidine (PEN), an advanced glycation end product (AGE), is associated with various age-related diseases and schizophrenia. This study aimed to identify the natural compounds that inhibit PEN synthesis from glucuronic acid using an <em>in vitro</em> system. A screening of 93 natural compounds revealed 47 that reduced PEN synthesis by > 50 %, with eight inhibiting it by > 80 %. The top five inhibitors were anthocyanins, with petunidin chloride showing the strongest effect, inhibiting PEN synthesis by approximately 90 %. These compounds directly inhibited PEN synthesis without degrading or capturing the synthesized PEN. Petunidin chloride had an IC<sub>50</sub> value approximately 85 times lower than that of pyridoxamine, an AGE inhibitor. A correlation between the antioxidant capacity of the compounds and their PEN-inhibitory effects was observed, suggesting that antioxidant properties may contribute to the inhibition mechanism. This study provides potential new therapeutic strategies for diseases associated with PEN accumulation, including schizophrenia, and highlights the potential of anthocyanins in the development of safer preventive interventions.</div></div>","PeriodicalId":8779,"journal":{"name":"Biochemical and biophysical research communications","volume":"740 ","pages":"Article 151007"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Anthocyanins as potent inhibitors of pentosidine synthesis: Antioxidant-mediated effects\",\"authors\":\"Mai Asakura , Kazuya Toriumi , Aya Nozaki , Jinwei Yang , Jin Tatsuzaki , Kazuhiro Suzuki , Mitsuhiro Miyashita , Masanari Itokawa , Makoto Arai\",\"doi\":\"10.1016/j.bbrc.2024.151007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Pentosidine (PEN), an advanced glycation end product (AGE), is associated with various age-related diseases and schizophrenia. This study aimed to identify the natural compounds that inhibit PEN synthesis from glucuronic acid using an <em>in vitro</em> system. A screening of 93 natural compounds revealed 47 that reduced PEN synthesis by > 50 %, with eight inhibiting it by > 80 %. The top five inhibitors were anthocyanins, with petunidin chloride showing the strongest effect, inhibiting PEN synthesis by approximately 90 %. These compounds directly inhibited PEN synthesis without degrading or capturing the synthesized PEN. Petunidin chloride had an IC<sub>50</sub> value approximately 85 times lower than that of pyridoxamine, an AGE inhibitor. A correlation between the antioxidant capacity of the compounds and their PEN-inhibitory effects was observed, suggesting that antioxidant properties may contribute to the inhibition mechanism. This study provides potential new therapeutic strategies for diseases associated with PEN accumulation, including schizophrenia, and highlights the potential of anthocyanins in the development of safer preventive interventions.</div></div>\",\"PeriodicalId\":8779,\"journal\":{\"name\":\"Biochemical and biophysical research communications\",\"volume\":\"740 \",\"pages\":\"Article 151007\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemical and biophysical research communications\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0006291X24015432\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical and biophysical research communications","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0006291X24015432","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Anthocyanins as potent inhibitors of pentosidine synthesis: Antioxidant-mediated effects
Pentosidine (PEN), an advanced glycation end product (AGE), is associated with various age-related diseases and schizophrenia. This study aimed to identify the natural compounds that inhibit PEN synthesis from glucuronic acid using an in vitro system. A screening of 93 natural compounds revealed 47 that reduced PEN synthesis by > 50 %, with eight inhibiting it by > 80 %. The top five inhibitors were anthocyanins, with petunidin chloride showing the strongest effect, inhibiting PEN synthesis by approximately 90 %. These compounds directly inhibited PEN synthesis without degrading or capturing the synthesized PEN. Petunidin chloride had an IC50 value approximately 85 times lower than that of pyridoxamine, an AGE inhibitor. A correlation between the antioxidant capacity of the compounds and their PEN-inhibitory effects was observed, suggesting that antioxidant properties may contribute to the inhibition mechanism. This study provides potential new therapeutic strategies for diseases associated with PEN accumulation, including schizophrenia, and highlights the potential of anthocyanins in the development of safer preventive interventions.
期刊介绍:
Biochemical and Biophysical Research Communications is the premier international journal devoted to the very rapid dissemination of timely and significant experimental results in diverse fields of biological research. The development of the "Breakthroughs and Views" section brings the minireview format to the journal, and issues often contain collections of special interest manuscripts. BBRC is published weekly (52 issues/year).Research Areas now include: Biochemistry; biophysics; cell biology; developmental biology; immunology
; molecular biology; neurobiology; plant biology and proteomics